COVID-19 in Russian Federation: 400K cases, Avifavir approved for treatment

Cheryl Sanders
June 3, 2020

The final stage of avifavir clinical trials involving 330 patients is ongoing at 35 medical centres across Russian Federation.

Avifavir, originally developed to combat severe forms of influenza, demonstrated the ability to disrupt the reproductive mechanisms of COVID-19 in clinical trials.

Russian Federation confirmed 8,952 new COVID-19 cases in the last 24 hours, raising its total number of infections to 396,575, its coronavirus response center said in a statement Saturday.

Moscow, the country's worst-hit region, confirmed 2,367 new cases in the last 24 hours, taking its total to 178,196.

Russian hospitals will probably start to give medicine to patients on June 11, and it is enough for 60,000 people a month, said in an interview with Reuters, the head of the Russian direct investment FUND, which provides financial support to advancement of Japanese medicine.

The trials were due to be concluded in around a week, he said, but the health ministry had given its approval for the drug's use under a special accelerated process and manufacturing had begun in March.

"It's a major, major step forward", RDIF CEO Kirill Dmitriev told CNBC Monday. Japan has been trialling the same drug, which is known there as Avigan.

The COVID-19 pandemic has reportedly infected almost 6 million people globally and has claimed the life of more than 369,000 patients.

The plan for the trial is to test the medication on 330 patients, the drug has already been tested with 188 patients, Chulanov said. "It will reduce strain on the healthcare system, we'll have fewer people getting into a critical condition, and for 90% of people it eliminates the virus within 10 days", he said. Since yesterday the infection claimed 138 lives, bringing the death toll to 4,693. Prime Minister Shinzo Abe praised about it, and the government allocated $128 million to complete the development, but the official registration is still pending. It was developed in Japan, it was used during the flu epidemic in 2014.

Other reports by iNewsToday